相关实验视频

Updated: Jan 7, 2026

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

模块化CAR T细胞的当前景观

Alexander Haide Joechner¹, Melanie Mach^1,2, Ziduo Li^1,3

¹Biosceptre (Aust) Pty Ltd., Westmead, NSW 2145, Australia.

International journal of molecular sciences

|December 30, 2025

概括

模块化CAR T细胞通过将抗原识别与T细胞激活分开,为癌症治疗提供了更好的控制和灵活性. 与传统的CAR T细胞治疗相比,这种可适应的系统提高了安全性和精度.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

目前的CAR T细胞疗法取得了成功,但存在严重不良事件和抗原阴性复发等局限性.
未满足的临床需求持续存在,推动对更可控制,可编程和可组合的CAR T细胞治疗瘤学和自身免疫的需求.

研究的目的:

介绍和详细阐述模块化CAR T细胞系统的设计原则和优势.
要突出模块化如何解决直接向CAR T细胞的局限性,提高安全性,灵活性和治疗潜力.

主要方法:

模块化CAR T细胞利用一个由两个组成部分组成的系统:CAR在T细胞上与适应分子 (AM) 结合,这反过来又与瘤相关抗原 (TAA) 结合.
这种设计将目标识别与T细胞激活分开,允许可适应的准和逻辑控制.
关键的设计考虑因素包括CAR架构,相互作用的亲和力 (CAR-AM和AM-TAA),AM价值,以及AM架构 (大小).

主要成果:

模块化CAR T细胞通过将抗原识别与T细胞激活脱而出,提供了增强的控制,灵活性和安全性.
适配器分子 (AM) 是可交换的,可以轻松进行多重复合和基于逻辑的准,而不需要重新设计T细胞.
设计参数如CAR架构,结合亲和性,AM价值和大小显著影响系统性能,药理动力学和剂量.

结论:

模块化CAR T细胞技术提出了一个有希望的战略,以克服直接向CAR T细胞的局限性,潜在地减轻不良事件和抗原逃逸.
该系统在目标抗原切换和AM剂量响应调制方面的灵活性可能对治疗异质癌症至关重要.
自2012年以来,已经开发了30多种模块化CAR结构,其中一些已经进入早期临床试验阶段,表明了治疗潜力.

关键词:

在CAR T细胞中.汽车适配器汽车适配器适配器分子 (AM) 适配器分子抗原受体的抗原受体是什么间接的CAR 间接的CAR 模块化的汽车汽车.可切换的CAR可以切换.

更多相关视频

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

相关概念视频

T Cell Activation and Clonal Selection

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.